QUANTIPLEX
Live / Registered — Registered — Section 71 accepted (as of 01 Jun 2024)
What this means for you
Registered since 24 Sept 2013. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79124568
- Registration number
- 4405272
- Mark type
- Stylized text
- Filed
- 12 Dec 2012
- Published for opposition
- 09 Jul 2013
- Registered
- 24 Sept 2013
- Attorney of record
- Victoria Friedman
Goods and services
- Class 001 — Chemicals: Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, [ diagnostic preparations except for human or veterinary medical purposes, namely, nonmedical ] reagents, enzymes and buffer solutions for [ scientific and medical research use for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for ] nucleic acid amplification by polymerase chain reaction (PCR) [ ; kits comprising chemicals for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, nucleic acids of biological or biochemical sample material comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR) ]
- Class 005 — Pharmaceuticals: [ Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); chemical, biochemical and biotechnological preparations, namely, reagents, enzymes and buffer solutions for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances for diagnostic medical and clinical use, namely, reagents, enzymes and buffer solutions for nucleic acid amplification by polymerase chain reaction (PCR); ] kits containing [ preparations for medical and veterinary diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating and analyzing biopolymers in the nature of nucleic acids from biological or ] biochemical sample material for nucleic acid amplification by polymerase chain reaction (PCR)
Owner
- QIAGEN GmbH, Hilden, DE
- QIAGEN GmbH, DE
- QIAGEN GmbH, DE
Prosecution history
- 03 May 2025 — PARTIAL INVALIDATION PROCESSED BY THE IB
- 14 Apr 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
- 14 Apr 2025 — INVALIDATION PROCESSED
- 01 Feb 2025 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 01 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 01 Jun 2024 — REGISTERED-SEC.71 ACCEPTED
- 28 May 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 13 May 2024 — POST REGISTRATION ACTION MAILED - SEC.71
- 05 May 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Sept 2023 — TEAS SECTION 71 RECEIVED
- 30 Dec 2022 — INTERNATIONAL REGISTRATION RENEWED
- 24 Sept 2022 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 27 Aug 2019 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 27 Aug 2019 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Aug 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL